Folate receptor type β is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia

Cancer

Volumn 85, Issue 2, 1999, Pages 348-357

  Ross, John F ^a   Wang, Hui ^a   Behm, Frederick G ^b   Mathew, Prasad ^a   Wu, Marietta ^a   Booth, Robert ^a   Ratnam, Manohar ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

CD antigens; Differentiation marker; Folate receptor; Leukemia

Indexed keywords

FOLIC ACID; RECEPTOR SUBTYPE; VITAMIN RECEPTOR;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BLOOD SMEAR; BONE MARROW BIOPSY; CELL LINEAGE; CELL SPECIFICITY; CONTROLLED STUDY; ERYTHROLEUKEMIA; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LEUKEMIA CELL; MYELOID LEUKEMIA; MYELOMONOCYTIC LEUKEMIA; NEUTROPHIL; NONHUMAN; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROGNOSIS; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; BIOLOGICAL MARKERS; CARRIER PROTEINS; CELL DIFFERENTIATION; CHO CELLS; CRICETINAE; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA, MYELOID; LEUKOCYTES, MONONUCLEAR; NEUTROPHILS; RABBITS; RECEPTORS, CELL SURFACE;

EID: 0032916448     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990115)85:2<348::AID-CNCR12>3.0.CO;2-4     Document Type: Article

References (37)

1. Antony, AC. The biological chemistry of folate receptors. Blood 1992;79:2807-20.
2. Elwood PC. Molecular cloning and characterization of the human folate-binding protein cDNA from placenta and malignant tissue culture (KB) cells. J Biol Chem 1989;264:14893-901.
3. Lacey SW, Sanders JM, Rothberg KG, Anderson RGW, Kamen BA. Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosylphosphatidylinositol. J Clin Invest 1989;84:715-20.
4. Ratnam M, Marquardt H, Duhring JL, Freisheim JH. Homologous membrane folate binding proteins in human placenta: cloning and sequence of a cDNA. Biochemistry 1989; 28:8249-54.
5. Shen F, Ross JF, Wang X, Ratnam M. Identification of a novel folate receptor, a truncated receptor, and a receptor type b in hematopoietic cells: cloning, expression, immunoreactivity, and tissue specificity. Biochemistry 1994;33: 1209-15.
6. Shen F, Wu M, Ross JF, Miller D, Ratnam M. Folate receptor type g is primarily a secretory protein due to lack of an efficient signal for glyeosylphosphatidylinositol modification: protein characterization and cell type specificity. Biochemistry 1995;34:5660-5.
7. Wang J, Shen F, Wu M, Ratnam M. Proteolysis of the carboxyl-terminal GPI signal independent of GPI modification as a mechanism for selective protein secretion. Biochemistry 1997;36:14583-92.
8. Shen F, Wang H, Zheng X, Ratnam M. Expression levels of functional folate receptors α and β are related to the number of N-glycosylated sites. Biochem J 1997;327:759-64.
9. Luhrs CA, Slomiany BL. A human membrane-associated folate binding protein is anchored by a glycosylphosphatidylinositol tail. J Biol Chem 1989;264:21446-9.
10. Verma RS, Gullapalli S, Antony AC. Evidence that the hydrophobicity of isolated, in situ, and de novo-synthisized native human placental folate receptors is a function of glycosylphosphatidylinositol anchoring to membranes. J Biol Chem 1992;267:4119-27.
11. Van W, Ratnam M. Preferred sites of glycosylphosphatidyli-nositol modification in folate receptors and constraints in the primary structure of the hydrophobic portion of the signal. Biochemistry 1995;34:14594-600.
12. Ross JF, Chaudhuri PK, Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines: physiologic and clinical implications. Cancer 1994;73:2432-43.
13. Campbell IG, Jones TA, Foulkes WD, Trowsdale J. Folate-binding protein is a marker for ovarian cancer. Cancer Res 1991;51:5329-38.
14. Coney LR, Tomassetti A, Carayannopoulos L, Frasca V, Kamen BA, Colnaghi MI, et al. Cloning of a tumor-associated antigen: Mov18 and Mov19 antibodies recognize a folate-binding protein. Cancer Res 1991;51:6125-32.
15. Weitman SD, Lark RH, Coney LR, Fort DW, Frasca V, Zurawski VR, Jr., et al. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res 1992;52:3396-401.
16. Wang X, Shen F, Freisheim JH, Gentry LE, Ratnam M. Differential stereospecificities and affinities of folate receptor isoforms for folate compounds and antifolates. Biochem Pharmacol 1992;44:1898-901.
17. Brigle KE, Spinella MJ, Westin EH, Goldman ID. Increased expression and characterization of two distinct folate binding proteins in murine erythroleukemia cells. Biochem Pharmacol 1994;47:337-45.
18. Jansen G, Schornagel JH, Westerhof GR, Rijksen G, Newell DR, Jackman AL. Multiple membrane transport systems for the uptake of folate-based thymidylate synthase inhibitors. Cancer Res 1990;50:7544-8.
19. Westerhof GR, Jansen G, Emmerik NV, Kathmann I, Rijksen G, Jackman AL, et al. Membrane transport of natural folates and antifolate compounds in murine L1210 leukemia cells: role of carrier- and receptor-mediated transport systems. Cancer Res 1991;51:5507-13.
20. Pizzorno G, Cashmore AR, Moroson BA, Cross AD, Smith AK, Marling-Cason M, et al. 5,10-Dideazatetrahydrofolic acid (DDATHF) transport in CCRF-CEM and MA104 cell lines. J Biol Chem 1993;268:1017-23.
21. Westerhof GR, Schornagel JH, Kathmann I, Rosowsky A, Forsch RA, Hynes JB, et al. Carrier and receptor-mediated transport of folate antagonist targeting folate-dependent enzymes: correlates of molecular structure and biological activity. Mol Pharmacol 1995;48:459-71.
22. Wu M, Fan J, Gunning W, Ratnam M. Clustering of GPI anchored folate receptor independent of both cross-linking and association with caveolin. J Membr Biol 1997;159:137-47.
23. Leamon CP, Low PS. Cytotoxicity of momordin-folate conjugates in cultured human cells. J Biol Chem 1992;267: 24966-71.
24. Leamon CP, Low PS. Selective targeting of malignant cells with cytotoxin-folate conjugates. J Drug Targeting 1994;2: 101-12.
25. Leamon CP, Pastan I, Low P. Cytotoxicity of folate-pseudomonas exotoxin conjugates toward tumor cells. J Biol Chem 1993;268:24847-54.
26. Lee RJ, Low PS. Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J Biol Chem 1994; 269:3198-204.
27. Lee RJ, Low PS. Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. Biochim Biophys Acta 1995;1233:134-44.
28. Mathias CJ, Wang S, Lee RJ, Waters DJ, Low PS, Green MA. Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate. J Nucl Med 1996;37:1103-8.
29. Mazzoni A, Mezzanzanica D, Jung G, Wolf H, Colnaghi MI, Canevari S. CD3-CD28 costimulation as a means to avoiding T cell preactivation in bispecific monoclonal antibody-based treatment of ovarian carcinoma. Cancer Res 1996;56: 5443-9.
30. Mezzanzanica D, Canevari S, Colnaghi MI. Retargeting of human lymphocytes against human ovarian carcinoma cells by bispecific antibodies: from laboratory to clinic. Int J Clin Lab Res 1991;21:159-64.
31. Mezzanzanica D, Garrido MA, Neblock DS, Daddona PE, Andrew SM, Zurawski VR, et al. Human T-lymphocytes targeted against an established human ovarian carcinoma with a bispecific F(ab′)2 antibody prolong host survival in a murine xenograft model. Cancer Res 1991;51:5716-21.
32. Ferrini S, Cambiaggi A, Storzini S, Canevari S, Mezzanzanica D, Colnaghi MI, et al. Use of anti-CD3 and anti-CD16 bispecific monoclonal antibodies for the targeting of T and NK cells against tumor cells. Cancer Detect Prev 1993;17:295-300.
33. Canevari S, Mezzanzanica D, Mazzoni A, Negri DR, Ramakrishna V, Bolhuis RL, et al. Bispecific antibody targeted T cell therapy of ovarian cancer: clinical results and future directions. J Hematotherapy 1995;4:423-7.
34. Sadasivan E, da Costa M, Rothenberg SP, Brink L. Purification, properties, and immunological characterization of folate-binding proteins from human leukemia cells. Biochim Biophys Acta 1987;925:36-47.
35. Sadasivan E, Rothenberg SP, da Costa M, Brink L. Characterization of mutiple forms of folate-binding protein from human leukemia cells. Biochim Biophys Acta 1986;882:311-21.
36. Kane MA, Elwood PC, Portillo RM, Antony AC, Kolhouse JF. The interrelationship of the soluble and membrane-associated folate-binding proteins in human KB cells. J Biol Chem 1986;261:15625-31.
37. Syrjälä M, Ruutu T, Jansson SE. A flow cytometric assay of CD34-positive cell populations in the bone marrow. Br J Haematol 1994;88:679-84.